MODTX.ST
Modus Therapeutics Holding AB (publ) [MODTX.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MODTX.ST Stock Summary
Top 10 Correlated ETFs
MODTX.ST
Top 10 Correlated Stocks
MODTX.ST
In the News
MODTX.ST Financial details
Company Rating
-
Market Cap
37.38M
Income
-29.51M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
22 Nov 2022
P/E
-0.99
Forward P/E
-
PEG
-0.18
P/S
-
P/B
-2.11
P/C
-
P/FCF
-3.55
Quick Ratio
0.18
Current Ratio
0.24
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-1.76
EPS next Y
-
EPS next Q
-
EPS this Y
-11.4%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-5.26%
-
-
-
-
SMA20
10.32%
SMA50
9.45%
SMA100
-25.27%
Inst Own
-
Inst Trans
-
ROA
-658%
ROE
340%
ROC
0.62%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.01-3.6
52W High
-52.67%
52W Low
+42%
RSI
54.88
Rel Volume
2.66
Avg Volume
25.93K
Volume
69.09K
Perf Week
2.16%
Perf Month
17.36%
Perf Quarter
9.23%
Perf Half Y
9.23%
-
-
-
-
Beta
0.41
-
-
Volatility
0.04%, 0.08%
Prev Close
-0.7%
Price
1.42
Change
0%
Company Profile
- Volume Average 25.93K
- Market Capitalization 37.38M
- Employee 2
- CEO Dr. John Öhd M.D., Ph.D.
- Headquarters Stockholm,SE
- IPO Date 2021-07-22
-
Website
https://www.modustx.com 
Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. Its lead product is Sevuparin, a polysaccharide to treat patients with sepsis and septic shock, which is under Phase Ib clinical study. The company was founded in 2011 and is headquartered in Stockholm, Sweden.
